|
| 35976415 | A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer. | Cancer Immunol Immunother | 2023 |
| 37806255 | Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study). | Eur J Cancer | 2023 |
| 38061007 | Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer. | JCO Precis Oncol | 2023 |
| 37536738 | <sup>68</sup>Ga-PSMA PET/CT for Response Evaluation of <sup>223</sup>Ra Treatment in Metastatic Prostate Cancer. | J Nucl Med | 2023 |
| 37461156 | Improved enrichment of circulating tumor cells from diagnostic leukapheresis product. | Cytometry A | 2023 |
| 37178439 | mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer. | Mol Oncol | 2023 |
| 37400554 | The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. | Sci Rep | 2023 |
| 37434119 | The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs. | BMC Cancer | 2023 |
| 36996325 | Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer. | Clin Cancer Res | 2023 |
| 34446849 | Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223. | Prostate Cancer Prostatic Dis | 2022 |
| 35654644 | Corrigendum to "Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study". | Urol Oncol | 2022 |
| 35927345 | Discontinuation of azacitidine in acute myeloid leukemia: a feasible option? | Ann Hematol | 2022 |
| 35895277 | Influence of Darolutamide on Cabazitaxel Systemic Exposure. | Clin Pharmacokinet | 2022 |
| 36323051 | CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients. | Eur J Cancer | 2022 |
| 35059789 | Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic castration-resistant prostate cancer: a case report. | Cancer Chemother Pharmacol | 2022 |
| 34615720 | Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells. | Clin Cancer Res | 2022 |
| 33317946 | Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers. | Clin Genitourin Cancer | 2021 |
| 34944897 | RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2021 |
| 34409743 | Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer. | J Thromb Haemost | 2021 |
| 34475104 | Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types. | Clin Cancer Res | 2021 |
| 34249756 | Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients. | Front Oncol | 2021 |
| 33932725 | Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells. | Eur J Cancer | 2021 |
| 33974560 | 11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration. | JCI Insight | 2021 |
| 31748122 | Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study. | Eur Urol Focus | 2021 |
| 33428771 | The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure. | Int J Cancer | 2021 |
| 33356721 | Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). | Acta Oncol | 2021 |
| 32169916 | <sup>68</sup>Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer. | J Nucl Med | 2020 |
| 31875956 | A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population. | Int J Cancer | 2020 |
| 32680820 | Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study. | Urol Oncol | 2020 |
| 32408351 | Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study. | Clin Chem | 2020 |
| 29392602 | "Duodenal Adenocarcinoma Giving Rise to Rectal Metastasis" a Rare Disease with an Extremely Rare Metastatic Pattern. | J Gastrointest Cancer | 2019 |
| 31748536 | The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact. | Nat Commun | 2019 |
| 31180178 | AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel. | Mol Oncol | 2019 |
| 31434336 | Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel. | Cancers (Basel) | 2019 |
| 31515667 | A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics. | Cancer Chemother Pharmacol | 2019 |
| 31542641 | Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer. | Eur J Cancer | 2019 |
| 31125423 | The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study). | Clin Pharmacol Ther | 2019 |
| 30737835 | Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug-drug interaction study. | Br J Clin Pharmacol | 2019 |
| 30761532 | Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer. | Int J Cancer | 2019 |
| 30907154 | Mannose binding lectin and prediction of risk for chemotherapy induced febrile neutropenia in patients with a solid tumor. | Cancer Invest | 2019 |
| 30756132 | Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus. | Cancer Immunol Immunother | 2019 |
| 30296589 | An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA. | J Mol Diagn | 2019 |
| 30652208 | The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial. | Cancer Immunol Immunother | 2019 |
| 30544060 | A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy. | Eur J Cancer | 2019 |
| 30367352 | Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients. | Clin Pharmacokinet | 2019 |
| 30413837 | Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma. | Cancer Immunol Immunother | 2019 |
| 28667459 | Clinical Pharmacokinetics and Pharmacodynamics of Panobinostat. | Clin Pharmacokinet | 2018 |
| 30348537 | DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis. | Lancet Oncol | 2018 |
| 29474983 | An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor Cells. | J Mol Diagn | 2018 |
| 29204933 | Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. | Int J Clin Oncol | 2018 |